Financial Data and Key Metrics Changes - Sales in Q4 were $1.1 billion, representing an increase of 5% in local currency or 4% excluding acquisitions, and an 8% increase on a reported basis in US dollars [7] - Adjusted EPS for the quarter was $13.36, an 8% increase over the prior year, while reported EPS was $13.98 compared to $11.96 in the prior year [10][11] - Gross margin was 59.8%, a decrease of 140 basis points, impacted by unfavorable foreign currency and incremental gross tariff costs [8][9] - Adjusted operating profit amounted to $363 million, up 3% versus the prior year, with an adjusted operating margin of 32.1%, a decrease of 160 basis points [9][11] Business Line Data and Key Metrics Changes - Laboratory sales increased 3% in Q4, while industrial sales increased 7%, including a 3% benefit from acquisitions [7][8] - Food retail sales grew 19% in the quarter, and service revenue grew 8%, including a 2% benefit from acquisitions [8] - For the full year, local currency sales increased 3%, with adjusted operating profit declining 1% and adjusted EPS increasing 4% [11][12] Market Data and Key Metrics Changes - Local currency sales in the Americas increased 7%, Europe increased 4%, and Asia (rest of the world) also increased 4% [7] - Local currency sales in China increased 3% during the quarter, with modest growth expected in the lab and industrial segments [24][25] - Emerging markets outside of China accounted for 18% of sales in 2025 and grew above the company average due to dedicated resources and growth initiatives [25] Company Strategy and Development Direction - The company is focused on driving growth through the Spinnaker sales and marketing program and innovative product portfolio, capitalizing on automation, digitalization, and onshoring investments [6][19] - The company aims to maintain a strong culture of innovation and operational excellence to gain market share and deliver strong financial performance [6][26] - Future growth opportunities are anticipated from customer replacement cycles and investments in on- and nearshoring activities [26] Management's Comments on Operating Environment and Future Outlook - Management noted that while there have been favorable headlines in the pharma and life sciences markets, customers are expected to be cautious with investments at the start of the year [31][32] - The company does not anticipate significant improvement in market conditions in 2026 compared to the previous year, but remains confident in executing growth and productivity initiatives [14][15] - Management highlighted the importance of their innovative portfolio and strong global leadership positions in navigating ongoing market challenges [26] Other Important Information - Free cash flow for 2025 was $878 million, with a conversion ratio of 99% of adjusted net income [12] - Guidance for 2026 includes local currency sales growth forecast of approximately 4%, with adjusted EPS expected to be in the range of $46.05-$46.70, representing a growth rate of 8%-9% [15][18] Q&A Session Summary Question: Customer caution in pharma and life sciences - Management acknowledged that despite positive headlines, there is still uncertainty in the market leading to longer deal cycles and a cautious start to the year [31][32] Question: Components of guidance for pricing and volume - Management indicated that pricing is expected to start the year stronger due to mid-year pricing actions from the previous year, with a forecast of 3.5% for Q1 and 2.5% for the full year [34][35] Question: Growth in food retail - Management noted that food retail is a lumpy business with project-based revenue, and while they are pleased with Q4 performance, they expect flat growth for the full year 2026 due to tough comparisons [55][56] Question: Outlook for China and pharmacopoeia opportunity - Management stated that while there is good engagement in China, the pharmacopoeia opportunity will support ongoing growth but is not expected to result in a significant step change [57][75] Question: Reshoring and onshoring opportunities - Management views reshoring as a longer-term opportunity, likely materializing in 2027 and beyond, as factories need to be built before orders can be realized [61][62] Question: Performance in Europe - Management highlighted strong performance in Europe despite a softer economy, driven by effective sales strategies and innovation in product offerings [66][68] Question: Service business outlook - Management expects mid- to high-single-digit growth for the service business in 2026, with continued focus on penetrating the serviceable addressable market [70][71]

Core Viewpoint - The rapid production of humanoid robots is expected to enhance the performance of the automation equipment sector, which is a high-end manufacturing area with export advantages [1] Industry Summary - The automation equipment sector is benefiting from the demand for manufacturing upgrades, leading to improved annual report performance [1] - The acceleration in the mass production of humanoid robots is anticipated to drive demand for core components such as joint modules, lead screws, and reducers [1] - The production recovery in automation equipment is showing steady growth in demand, with expectations for improved annual report performance [1] Company Summary - The Guotai Robot ETF (159551) tracks the robot index (H30590), which focuses on the robotics-related industry [1] - This index selects listed companies involved in the research, manufacturing, and application of robots to reflect the overall performance of securities in automation and intelligent manufacturing [1] - The index emphasizes market trends in the robotics industry, including sectors with high technological content and growth potential, such as industrial automation, service robots, and artificial intelligence [1]

Investment Rating - The investment rating for the company is "Buy" [5] Core Insights - The company is expected to turn profitable in Q4 2025, with a projected net profit of between 0.03 billion to 0.63 billion yuan, marking a significant recovery from a loss of 3.30 billion yuan in the same quarter of 2024 [2] - The company has diversified its operations across multiple sectors including lithium batteries, consumer electronics, photovoltaics, and medical fields, which supports its growth strategy [3] - The company has successfully expanded its overseas business, achieving a 192.5% year-on-year increase in new overseas orders in the first half of 2025, totaling 18.88 billion yuan [3] Financial Performance - For 2025, the company is projected to have a net profit of between -8.5 billion to -9.1 billion yuan, indicating an increase in losses compared to the previous year [2] - The company expects to achieve a net profit of 4.1 billion yuan in 2026 and 7.4 billion yuan in 2027, with a significant growth rate of 81% in 2027 compared to 2026 [5] - The revenue for 2025 is estimated at 4.09 billion yuan, a decrease of 10% from 2024, but is expected to rebound to 6.02 billion yuan in 2026, representing a 47% increase [7] Order and Market Dynamics - The company has seen a significant improvement in order intake, with new orders reaching 100.85 billion yuan in the first half of 2025, a year-on-year growth of approximately 117.5% [4] - As of June 30, 2025, the company had a backlog of orders amounting to 100.85 billion yuan, reflecting a 46% increase year-on-year [4]

Investment Rating - The investment rating for the company is "Buy" [5] Core Insights - The company is expected to turn profitable in Q4 2025, with a projected net profit of between 0.03 billion to 0.63 billion yuan, marking a significant recovery from a loss of 3.30 billion yuan in the same quarter of 2024 [2] - The company has diversified its operations across multiple sectors including lithium batteries, consumer electronics, photovoltaics, and medical fields, which supports its growth strategy [3] - The company has successfully expanded its overseas business, achieving a 192.5% year-on-year increase in new overseas orders in the first half of 2025, totaling 18.88 billion yuan [3] Financial Performance - For 2025, the company is projected to have a net profit of between -8.5 billion to -9.1 billion yuan, indicating an increase in losses compared to the previous year [2] - The company expects to achieve a net profit of 4.1 billion yuan in 2026 and 7.4 billion yuan in 2027, with a significant growth rate of 81% in 2027 compared to 2026 [5] - Revenue is forecasted to decline by 10% in 2025 but is expected to rebound with a growth of 47% in 2026 and 23% in 2027 [7] Order and Revenue Growth - The company received new orders worth 100.85 billion yuan in the first half of 2025, representing a year-on-year growth of approximately 117.5% [4] - As of June 30, 2025, the company had a backlog of orders amounting to 100.85 billion yuan, a 46% increase compared to the previous year [4]

证券之星消息，2月4日自动化设备板块较上一交易日下跌0.9%，田中精机领跌。当日上证指数报收于 4102.2，上涨0.85%。深证成指报收于14156.27，上涨0.21%。自动化设备板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300461 | 田中精机 | 35.12 | -11.29% | 13.04万 | 5.40 Z | | 603025 | 大豪科技 | 16.25 | -7.35% | 23.25万 | 3.79亿 | | 920885 | 星辰科技 | 24.50 | -3.92% | 6.93万 | 1.71亿 | | 688017 | 绿的谐波 | 216.51 | -3.77% | 8.73万 | 18.91亿 | | 603203 | 快克智能 | 37.15 | -3.15% | 3.65万 | 1.36 Z | | 688090 | 瑞松科技 | 47.92 | -3.15% | 3.98万 | 1.91亿 | | 920405 | 海君通讯 ...

Core Viewpoint - Emerson Electric reported a 4% year-over-year increase in net sales for Q1 of fiscal year 2026, reaching $4.35 billion, aligning with analyst expectations [1] - Adjusted earnings per share (EPS) were $1.46, surpassing the analyst forecast of $1.41 [1] - The company raised its earnings guidance for fiscal year 2026, now expecting adjusted EPS to be between $6.40 and $6.55, up from the previous range of $6.35 to $6.55 [1] Financial Performance - Net sales increased by approximately 4% year-over-year to $4.35 billion [1] - Software and systems business sales grew by 5% year-over-year to $1.45 billion [1] - Adjusted EPS of $1.46 exceeded analyst expectations [1] Guidance Update - The company has updated its earnings guidance for fiscal year 2026 [1] - New adjusted EPS guidance is set between $6.40 and $6.55 [1] - Previous guidance was between $6.35 and $6.55 [1]

Market Overview - The automation equipment sector increased by 4.37% on February 3, with Robotech leading the gains [1] - The Shanghai Composite Index closed at 4067.74, up 1.29%, while the Shenzhen Component Index closed at 14127.1, up 2.19% [1] Top Performers - Robotech (300757) closed at 424.80, up 20.00% with a trading volume of 173,200 shares and a transaction value of 7.169 billion [1] - Jieyin Technology (688025) closed at 185.30, up 18.87% with a trading volume of 94,500 shares and a transaction value of 1.639 billion [1] - Bozhong Precision (688097) closed at 43.90, up 11.17% with a trading volume of 137,100 shares and a transaction value of 579 million [1] Market Capital Flow - The automation equipment sector saw a net inflow of 959 million from institutional investors, while retail investors experienced a net outflow of 368 million [2][3] - Major stocks like Zhongkong Technology (688777) had a net inflow of 432 million from institutional investors, but a net outflow of 204 million from retail investors [3] Individual Stock Performance - Kairui Technology (002957) had a net inflow of 184 million from institutional investors, but a net outflow of 97 million from retail investors [3] - Huagong Technology (0009888) saw a net inflow of 395 million from institutional investors, with a net outflow of 218 million from retail investors [3]

格隆汇2月3日｜罗博特科今日20cm涨停，成交额71.69亿元，换手率11.50%，盘后龙虎榜数据显示，深 股通专用席位买入7.75亿元并卖出2.03亿元，2家机构专用席位净买入2.04亿元。 ...

每经AI快讯，2月3日，罗博特科（300757）今日20cm涨停，成交额71.69亿元，换手率11.50%，盘后龙 虎榜数据显示，深股通专用席位买入7.75亿元并卖出2.03亿元，2家机构专用席位净买入2.04亿元。 ...

Market Performance - The A-share market experienced a rise, with the Shanghai Composite Index increasing by 0.38% to 4031.07 points, the Shenzhen Component Index rising by 0.93%, and the ChiNext Index up by 0.76% as of the morning close on February 3 [1] - The total trading volume for A-shares reached 1.62 trillion yuan [1] Monetary Policy - The People's Bank of China conducted a 7-day reverse repurchase operation of 105.5 billion yuan at an interest rate of 1.40%, with a net withdrawal of 296.5 billion yuan for the day [2] Industry Developments - The State-owned Assets Supervision and Administration Commission emphasized the need for further reforms in state-owned enterprises by 2026, focusing on income distribution management and technological innovation incentives [3] - By December 2025, there will be 6,233 new renewable energy projects, predominantly in solar power, with 6,190 solar projects and only 36 wind projects [3] Stock Performance - Stocks related to space photovoltaics and commercial aerospace saw significant gains, with over 20 stocks, including Aotewi and Jili Suoju, hitting the daily limit [3] - The battery sector showed strong performance, with various battery technologies such as BC Shenchu and TOPCon batteries seeing average increases of 5.88% and 4.94%, respectively [4] Company Insights - Aotewi has gained recognition in the optical communication sector, securing multiple orders from leading companies [8] - Robotech specializes in high-end automation equipment and has expanded its capabilities through the acquisition of ficonTEC, serving major clients like Intel and Huawei [8] - Dike Co. has achieved mass production of high-copper paste with a cost advantage of over 50% reduction in silver consumption, which is expected to improve profitability [8] - Laplace is enhancing its photovoltaic equipment technology and has adopted a platform-based product development model to improve efficiency and market responsiveness [8]